Home
Market Capitalization of Godavari Drugs Ltd

Godavari Drugs Ltd
NSE: GODAVARIDRUGS
Market Cap
Key Highlights
- The Market Cap of Godavari Drugs Ltd is ₹ 65.85 crore as of 21 Feb 25 .
- The Latest Trading Price of Godavari Drugs Ltd is ₹ 87.45 as of 21 Feb 15:30 .

Godavari Drugs Ltd
NSE: GODAVARIDRUGS
Share Price
Market Price of Godavari Drugs Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 87.45 |
20 Feb 2025 | 85.45 |
19 Feb 2025 | 87.25 |
18 Feb 2025 | 84.05 |
17 Feb 2025 | 87.35 |
14 Feb 2025 | 90 |
13 Feb 2025 | 93.7 |
12 Feb 2025 | 97.4 |
11 Feb 2025 | 101.35 |
10 Feb 2025 | 103.4 |
SWOT Analysis Of Godavari Drugs Ltd
BlinkX Score for Godavari Drugs Ltd
Asset Value vs Market Value of Godavari Drugs Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Godavari Drugs Ltd
Historical P/E Ratio of Godavari Drugs Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Godavari Drugs Ltd
Historical Revenue of Godavari Drugs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Godavari Drugs Ltd
Historical EBITDA of Godavari Drugs Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Godavari Drugs Ltd
Historical Net Profit of Godavari Drugs Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Godavari Drugs Ltd
Dividend Payout Over Time
About Godavari Drugs Ltd
- Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
- Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.
Godavari Drugs Ltd News Hub
Godavari Drugs standalone net profit rises 101.23% in the June 2024 quarter
Net profit of Godavari Drugs rose 101.23% to Rs 1.63 crore in the quarter ended June 2024 as against
Read more
14 Aug 24
Godavari Drugs to discuss results
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024. Power
Read more
10 Aug 24
Godavari Drugs standalone net profit rises 26.74% in the September 2024 quarter
Net profit of Godavari Drugs rose 26.74% to Rs 1.09 crore in the quarter ended September 2024 as aga
Read more
14 Nov 24
Godavari Drugs to convene board meeting
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powe
Read more
09 Nov 24